Department of General, Visceral and Vascular Surgery, University Hospital Jena, Am Klinikum 1, Erlanger Allee 101, 07740, Jena, Germany.
Department of Nuclear Medizine, University Hospital Jena, Am Klinikum1, 07740, Jena, Germany.
J Cancer Res Clin Oncol. 2023 Apr;149(4):1401-1410. doi: 10.1007/s00432-022-04009-x. Epub 2022 Apr 22.
Tumor recurrence is the leading cause of death after liver transplantation in patients with hepatocellular carcinoma. There is an ongoing debate as to whether metabolic indices such as tumor to liver standardized uptake value ratio in F-fluorodeoxyglucose positron emission tomography/computed tomography of the primary tumor can identify patients outside the Milan criteria with as low recurrence rates as patients inside Milan and thus should be added to the established prognostic factors.
This retrospective study analyzes 103 consecutive patients who underwent F-fluorodeoxyglucose positron emission tomography/computed tomography before liver transplantation for hepatocellular carcinoma using data of clinical tumor registry. Primary endpoints were overall survival and 10-year cumulative recurrence rates.
Tumor to liver standardized uptake value ratio of the primary tumor was statistically significant higher in Milan out tumors, "up-to-seven" out tumors, grade 3 tumors, α- fetoprotein level >400 ng/ml and lesions > 5cm in diameter. Factors with statistically significant influence on the 10- year overall survival in the univariate analysis were Milan, up-to-seven" criteria, number of lesions and pT-category. COX regression analysis did not show independently statistically significant factors for 10-year overall survival. Milan, "up-to-seven" criteria, grade, pV, number of lesions, size of lesion, pT-category, tumor to liver standardized uptake value ratio influenced 10-year cumulative recurrence rates statistically significant. Tumor to liver standardized uptake value ratio, grade and pT-category proved to be independently statistically significant factors for 10-year cumulative recurrence rates.
Our study suggests that tumor to liver standardized uptake value standardized uptake value ratio in F-fluorodeoxyglucose positron emission tomography/computed tomography is an independent prognostic factor in transplanted patients with hepatocellular carcinoma. If we focus on preoperative findings, such as tumor size, tumor number and AFP value adding the information given by TLR of F-FDG PET/CT allows to estimate the risk of tumor recurrence more accurate than the established classifications Milan and UTS. Therefore, it may add valuable information to other preoperative findings, such as tumor size, tumor number and AFP level.
肿瘤复发是肝癌患者肝移植后死亡的主要原因。目前,关于代谢指标(如原发性肿瘤 F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的肿瘤与肝脏标准化摄取比值)是否可以识别出米兰标准之外复发率与米兰标准内患者一样低的患者,以及这些代谢指标是否应添加到现有的预后因素中,仍存在争议。
本回顾性研究使用临床肿瘤登记处的数据,分析了 103 例因肝细胞癌行 F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描检查后行肝移植的连续患者。主要终点是总生存率和 10 年累积复发率。
在米兰肿瘤、“至七”肿瘤、3 级肿瘤、α-胎蛋白水平>400ng/ml 和直径>5cm 的肿瘤中,肿瘤与肝脏标准化摄取比值在统计学上显著较高。单因素分析中,对 10 年总生存率有统计学显著影响的因素为米兰、“至七”标准、病灶数量和 pT 分期。COX 回归分析未显示 10 年总生存率的独立统计学显著因素。米兰、“至七”标准、分级、pV、病灶数量、病灶大小、pT 分期、肿瘤与肝脏标准化摄取比值对 10 年累积复发率有统计学显著影响。肿瘤与肝脏标准化摄取比值、分级和 pT 分期被证明是 10 年累积复发率的独立统计学显著因素。
本研究表明,F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的肿瘤与肝脏标准化摄取比值是移植肝细胞癌患者的独立预后因素。如果我们关注术前发现,如肿瘤大小、肿瘤数量和 AFP 值,那么添加 F-FDG PET/CT 的 TLR 提供的信息可以比现有的米兰和 UTS 分类更准确地估计肿瘤复发的风险。因此,它可能会为肿瘤大小、肿瘤数量和 AFP 水平等其他术前发现提供有价值的信息。